NCT01254721View on ClinicalTrials.gov

A Comparison of the Effectiveness of Seroquel XR and Seroquel XR Plus Lithium in Patients With Acute Bipolar Mania: An Open-label, Randomized, Parallel Groups, Rater-blinded, 4 Week, Multicenter, Comparative,Study

PHASE4TerminatedINTERVENTIONAL
Enrollment

131

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Acute Bipolar Mania
Interventions
DRUG

Quetiapine fumarate

eXtended Release(XR) 50mg, 200mg, 300mg and/or 400mg tablet, oral, once daily in the evening, from assignment to the end of the study.

DRUG

lithium

300mg tablet, oral

Trial Locations (5)

Unknown

Research Site, Ansan

Research Site, Daegu

Research Site, Jinju

Research Site, Pusan

Research Site, Seoul

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY